Amarin (AMRN +1.2%) says the USPTO has granted a Notice of Allowance for patent protection of...

|About: Amarin Corporation PLC (AMRN)|By:, SA News Editor

Amarin (AMRN +1.2%) says the USPTO has granted a Notice of Allowance for patent protection of its Vascepa, a prescription grade omega-3 fatty acid that can help reduce triglyceride levels in adults. The issued patent would have a term that expires no earlier than in 2030.